Clinical trial NCT00281073 - References

Atrial Fibrillation — Intra-Cardiac Echocardiography Guided Cardioversion(ICE-CHIP) Study

Citation(s)

•   Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial
  Lancet. 1996 Sep 7;348(9028):633-8.
•   Castello R, Pearson AC, Labovitz AJ
  Prevalence and clinical implications of atrial spontaneous contrast in patients undergoing transesophageal echocardiography. Am J Cardiol. 1990 May 1;65(16):1149-53.
•   Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C
  Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol. 1991 Aug;18(2):349-55.
•   Epstein LM, Smith T, TenHoff H
  Nonfluoroscopic transseptal catheterization: safety and efficacy of intracardiac echocardiographic guidance. J Cardiovasc Electrophysiol. 1998 Jun;9(6):625-30.
•   Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Lévy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG; American College of Cardiology; American Heart Association; European Society of Cardiology; North American Society of Pacing and Electrophysiology
  ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J. 2001 Oct;22(20):1852-923.
•   Hijazi Z, Wang Z, Cao Q, Koenig P, Waight D, Lang R
  Transcatheter closure of atrial septal defects and patent foramen ovale under intracardiac echocardiographic guidance: feasibility and comparison with transesophageal echocardiography. Catheter Cardiovasc Interv. 2001 Feb;52(2):194-9.
•   Klein AL, Grimm RA, Murray RD, Apperson-Hansen C, Asinger RW, Black IW, Davidoff R, Erbel R, Halperin JL, Orsinelli DA, Porter TR, Stoddard MF; Assessment of Cardioversion Using Transesophageal Echocardiography Investigators
  Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med. 2001 May 10;344(19):1411-20.
•   Lin SL, Hsu TL, Liou JY, Chen CH, Chang MS, Chiang HT, Chen CY
  Usefulness of transesophageal echocardiography for the detection of left atrial thrombi in patients with rheumatic heart disease. Echocardiography. 1992 Mar;9(2):161-8.
•   Marrouche NF, Martin DO, Wazni O, Gillinov AM, Klein A, Bhargava M, Saad E, Bash D, Yamada H, Jaber W, Schweikert R, Tchou P, Abdul-Karim A, Saliba W, Natale A
  Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications. Circulation. 2003 Jun 3;107(21):2710-6. Epub 2003 May 19.
•   Mudra H, Klauss V, Blasini R, Kroetz M, Rieber J, Regar E, Theisen K
  Ultrasound guidance of Palmaz-Schatz intracoronary stenting with a combined intravascular ultrasound balloon catheter. Circulation. 1994 Sep;90(3):1252-61.
•   Olgin JE, Kalman JM, Fitzpatrick AP, Lesh MD
  Role of right atrial endocardial structures as barriers to conduction during human type I atrial flutter. Activation and entrainment mapping guided by intracardiac echocardiography. Circulation. 1995 Oct 1;92(7):1839-48.
•   Olsson SB; Executive Steering Committee of the SPORTIF III Investigators
  Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial. Lancet. 2003 Nov 22;362(9397):1691-8.
•   Packer DL, Stevens CL, Curley MG, Bruce CJ, Miller FA, Khandheria BK, Oh JK, Sinak LJ, Seward JB
  Intracardiac phased-array imaging: methods and initial clinical experience with high resolution, under blood visualization: initial experience with intracardiac phased-array ultrasound. J Am Coll Cardiol. 2002 Feb 6;39(3):509-16.
•   Pearson AC, Labovitz AJ, Tatineni S, Gomez CR
  Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. J Am Coll Cardiol. 1991 Jan;17(1):66-72.
•   Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B
  Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet. 1989 Jan 28;1(8631):175-9.
•   Petersen P, Grind M, Adler J; SPORTIF II Investigators
  Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. SPORTIF II: a dose-guiding, tolerability, and safety study. J Am Coll Cardiol. 2003 May 7;41(9):1445-51.
•   Ren JF, Marchlinski FE, Callans DJ
  Left atrial thrombus associated with ablation for atrial fibrillation: identification with intracardiac echocardiography. J Am Coll Cardiol. 2004 May 19;43(10):1861-7.
•   Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke
  EAFT (European Atrial Fibrillation Trial) Study Group. Lancet. 1993 Nov 20;342(8882):1255-62.
•   Shanewise JS, Cheung AT, Aronson S, Stewart WJ, Weiss RL, Mark JB, Savage RM, Sears-Rogan P, Mathew JP, Quiñones MA, Cahalan MK, Savino JS
  ASE/SCA guidelines for performing a comprehensive intraoperative multiplane transesophageal echocardiography examination: recommendations of the American Society of Echocardiography Council for Intraoperative Echocardiography and the Society of Cardiovascular Anesthesiologists Task Force for Certification in Perioperative Transesophageal Echocardiography. J Am Soc Echocardiogr. 1999 Oct;12(10):884-900.
•   Stroke Prevention in Atrial Fibrillation Study
  Final results. Circulation. 1991 Aug;84(2):527-39.
•   The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation
  The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. N Engl J Med. 1990 Nov 29;323(22):1505-11.
•   Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study
  Lancet. 1994 Mar 19;343(8899):687-91.

A Sequential Phase I - Phase II Pilot Study to Compare Cardiac Imaging Capabilities of ICE With TEE Followed by a Randomized Comparison of ICE Guided Cardioversion With Conventional Cardioversion Strategy in Patients With Atrial Fibrillation

Details for clinical trial NCT00281073